News & Updates
Filter by Specialty:
Survival benefit with postchemoradiation immunotherapy affirmed
Starting immunotherapy after chemotherapy and radiation for unresectable stage III nonsmall cell lung cancer (NSCLC) prolongs overall survival, regardless of patient age, health, and socioeconomic status, according to a large US study.
Survival benefit with postchemoradiation immunotherapy affirmed
15 Aug 2022Mammography screening tied to better breast cancer characteristics, outcomes
Regularly attending mammography screening sessions may lead to better breast cancer (BC) characteristics and help improve overall survival (OS), reports a recent Singapore study.
Mammography screening tied to better breast cancer characteristics, outcomes
15 Aug 2022Aquatic physical therapy boosts outcomes in women with breast cancer
Women with breast cancer may benefit significantly from aquatic physical therapy, which reduces fatigue while also improving quality of life (QoL), reports a recent meta-analysis.
Aquatic physical therapy boosts outcomes in women with breast cancer
13 Aug 2022Another breakthrough for HIV: Fourth patient goes into long-term remission
Hope springs yet again in the field of HIV treatment, as another HIV patient (reportedly the fourth in the world) goes into remission 3 decades following diagnosis. The patient stopped antiretroviral therapy (ART) after receiving allogeneic hematopoietic stem cell transplantation (HCT) of CCR5-Δ32/Δ32 donor cells for acute myelogenous leukaemia (AML).
Another breakthrough for HIV: Fourth patient goes into long-term remission
12 Aug 2022Teclistamab demonstrates clinical activity for R/R MM
The T-cell-redirecting bispecific antibody teclistamab induced deep and durable responses in patients with triple-class-exposed relapsed or refractory multiple myeloma (R/R MM), findings from the phase I/II MajesTEC-1 trial have shown.